A gathering of pharmaceutical executives comes as the sector has rebounded from uncertainty over Trump’s policies ...

The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Here's ...

Veteran immunologist and former Pfizer R&D leader joins Circurna to advance its circular RNA therapeutic platform ...

The collaboration will leverage Abalone Bio’s Functional Antibody Selection Technology platform for an undisclosed ...

The key drivers of increased investor interest in AstraZeneca are the strong performance of its oncology and cardiovascular ...

While the Trump administration remains unpredictable, some pharma experts are optimistic that the regulatory landscape will ...

Fourteen major pharmaceutical companies last year struck deals with the Trump administration to cut prices for some medicines ...

The early results showed that 15 of 41 evaluable patients had objective responses and 32 had stable disease with the ...

With Johnson & Johnson’s participation, 15 of 17 companies contacted by the administration over the summer have now signed on ...

MIT researchers are now turning the prolific Boltz series of models into a software company that promotes open science for AI-guided therapeutics.

Healthcare dealmakers are heading to San Francisco this weekend betting on a new wave of mega-mergers in 2026 that could ...

Zeno Group has hired Dana Gandsman as global managing director of health and wellness, effective January 5.